Casadevall A - Search Results

1

Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.

Jesus MD, Nicola AM, Chow SK, Lee IR, Nong S, Specht CA, Levitz SM, Casadevall A. Jesus MD, et al. Among authors: casadevall a. Virulence. 2010 Nov-Dec;1(6):500-8. doi: 10.4161/viru.1.6.13451. Epub 2010 Nov 1. Virulence. 2010. PMID: 21178496 Free PMC article.

2

Protective murine monoclonal antibodies to Cryptococcus neoformans.

Mukherjee J, Scharff MD, Casadevall A. Mukherjee J, et al. Among authors: casadevall a. Infect Immun. 1992 Nov;60(11):4534-41. doi: 10.1128/iai.60.11.4534-4541.1992. Infect Immun. 1992. PMID: 1398966 Free PMC article.

3

Monoclonal antibody based ELISAs for cryptococcal polysaccharide.

Casadevall A, Mukherjee J, Scharff MD. Casadevall A, et al. J Immunol Methods. 1992 Sep 18;154(1):27-35. doi: 10.1016/0022-1759(92)90209-c. J Immunol Methods. 1992. PMID: 1401941

4

Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.

Casadevall A, Mukherjee J, Devi SJ, Schneerson R, Robbins JB, Scharff MD. Casadevall A, et al. J Infect Dis. 1992 Jun;165(6):1086-93. doi: 10.1093/infdis/165.6.1086. J Infect Dis. 1992. PMID: 1583327

5

The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies.

Casadevall A, Scharff MD. Casadevall A, et al. J Exp Med. 1991 Jul 1;174(1):151-60. doi: 10.1084/jem.174.1.151. J Exp Med. 1991. PMID: 1676047 Free PMC article.

6

Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.

Mukherjee J, Feldmesser M, Scharff MD, Casadevall A. Mukherjee J, et al. Among authors: casadevall a. Antimicrob Agents Chemother. 1995 Jul;39(7):1398-405. doi: 10.1128/AAC.39.7.1398. Antimicrob Agents Chemother. 1995. PMID: 7492075 Free PMC article.

7

Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody.

Lee SC, Kress Y, Dickson DW, Casadevall A. Lee SC, et al. Among authors: casadevall a. J Neuroimmunol. 1995 Oct;62(1):43-52. doi: 10.1016/0165-5728(95)00097-l. J Neuroimmunol. 1995. PMID: 7499491

8

Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans.

Mukherjee J, Cleare W, Casadevall A. Mukherjee J, et al. Among authors: casadevall a. J Immunol Methods. 1995 Jul 17;184(1):139-43. doi: 10.1016/0022-1759(95)00097-t. J Immunol Methods. 1995. PMID: 7622865

9

Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Mukherjee J, Scharff MD, Casadevall A. Mukherjee J, et al. Among authors: casadevall a. Infect Immun. 1995 Sep;63(9):3353-9. doi: 10.1128/iai.63.9.3353-3359.1995. Infect Immun. 1995. PMID: 7642262 Free PMC article.

10

Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.

Goldman DL, Lee SC, Casadevall A. Goldman DL, et al. Among authors: casadevall a. Infect Immun. 1995 Sep;63(9):3448-53. doi: 10.1128/iai.63.9.3448-3453.1995. Infect Immun. 1995. PMID: 7642276 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,108 results

Search Page

Filters